EVT in Acute Basilar Artery Occlusion With Large Infarction Core
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe First Affiliated Hospital of Hainan Medical University
About this trial
A multicenter, prospective, open-label, blinded endpoint, randomized controlled trial designed to evaluate the efficacy and safety of best medical management (BMM) combined with endovascular treatment (EVT) versus BMM alone in acute basilar artery occlusion (BAO) patients with large infarct cores.
Eligibility criteria
Qualifiers
1. Age ≥18 years. 2. Symptoms and signs consistent with basilar artery ischemia. 3. Basilar artery or vertebral artery occlusion confirmed by computed tomography angiography (CTA), magnetic resonance angiography (MRA), digital subtraction angiography (DSA); if vertebral artery occlusion is present, it must completely obstruct blood flow to the basilar artery.
Disqualifiers
1. Pre-stroke modified Rankin Scale (mRS) score >2. 2. Factors in the target vessel that are expected to prevent completion of endovascular treatment.
Trial design
Treatments tested in this trial
- Endovascular Treatment
Treatment groups
348 Participants
are divided into 2 treatment groupsLocations
1First Affiliated Hospital of Hainan Medical University570100, HaikouHainan, China
Sponsors and collaborators
The First Affiliated Hospital of Hainan Medical University
Lead sponsor
Source ClinicalTrials.gov